乳腺癌中的新型PET标记剂用于治疗优化:临床实用性和未来前景
Laura Gilardi1, Lighea Simona Airò Farulla1,2, Elena Bonatto1
1Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS.
Current opinion in oncology
|July 16, 2024
概括
新型PET标记剂为治疗乳腺癌提供了新的途径. 这些先进的成像工具有助于通过评估瘤特征和预测各种乳腺癌亚型的治疗反应来个性化治疗.
科学领域:
- 在瘤学瘤学.
- 核医学就是核医学.
- 放射化学 放射化学是指辐射化学.
背景情况:
- 精确的乳腺癌管理依赖于及时的决策.
- 目前的成像方法在评估特定的乳腺癌亚型和治疗反应方面存在局限性.
研究的目的:
- 审查新型 pozitron发射断层扫描 (PET) 标记器的作用.
- 探索这些标记物如何优化各种乳腺癌亚型的治疗策略.
主要方法:
- 关于乳腺癌中PET标记物的现有文献的叙述性综述.
- 分析各种PET放射性药物的实用性,包括FDG,FES,HER2向和PARP向的标记物.
主要成果:
- FDG PET/CT对于转移性乳腺癌的反应评估是有价值的,但有局限性.
- FES PET/CT有助于评估雌激素受体 (ER) 状态并预测光线乳腺癌的反应.
- 针对HER2的标志物显示出对HER2状态评估的潜力,尽管反应预测是有争议的.
- 针对PARP的PET成像可能有助于为PARP抑制剂选择患者,特别是在三阴性乳腺癌 (TNBC) 中.
结论:
- 像FES,HER2向和PARP向的新型PET标记剂在个性化乳腺癌治疗方面表现有前途.
- 针对免疫检查点的PET成像可以帮助选择和监测TNBC治疗.
- 需要进一步的研究来验证这些针对性PET标记物的临床实用性,用于定制的乳腺癌疗法.
相关概念视频
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
105
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
105
01:29Positron Emission Tomography
4.1K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.1K